Jazz Pharmaceuticals Plc - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Jazz Pharmaceuticals, Inc. on April 2, 2008. The report discloses actions taken by the Compensation Committee of the Board of Directors regarding executive compensation adjustments and bonus awards.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation details.
Material Changes and Executive Compensation
On April 2, 2008, the Compensation Committee approved the following changes effective March 1, 2008:
- Base Salary Increases: Annual salary increases were approved for all named executive officers.
- 2007 Bonus Awards: Bonus awards were approved under the Cash Bonus Plan. These awards are split 50% in cash and 50% in stock awards under the 2007 Equity Incentive Plan.
- Stock Award Terms: Stock awards are fully vested on the grant date and are granted in consideration of past services. The number of shares will be determined based on the closing sales price on the first trading day of the next open stock trading window.
| Executive Officer | 2008 Base Salary | 2007 Bonus Award |
|---|---|---|
| Bruce C. Cozadd (Executive Chairman) | $442,000 | $115,000 |
| Samuel R. Saks, MD (CEO) | $468,000 | $140,000 |
| Robert M. Myers (President) | $444,000 | $140,000 |
| Matthew K. Fust (EVP & CFO) | $375,000 | $100,000 |
| Carol A. Gamble (SVP, General Counsel) | $357,000 | $95,000 |
| Janne L.T. Wissel (SVP, Chief Regulatory Officer) | $357,000 | $85,000 |
Note: Bruce C. Cozadd's base salary is prorated for 90% of his professional time devoted to the role of Executive Chairman.
Guidance, Outlook, and Risks
The filing does not contain guidance, outlook, management commentary on business performance, risks, contingencies, or unusual items beyond the compensation disclosures.
Key Facts for Investor Verification
- Verify the exact number of shares issued for the 50% stock portion of the bonuses once the next trading window opens.
- Confirm the effective date of the new base salaries (March 1, 2008) against payroll records.
- Review the terms of the 2007 Equity Incentive Plan to understand the specific conditions of the stock awards.
- Note that the filing text does not provide clear values for the company's overall financial performance (revenue, earnings, cash flow).